Role of Doppler Echoflowmetry to Define Risk Factors for the Development of Complications in Twin Pregnancies
Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Jan 17, 2025
Trial Information
Current as of August 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying twin pregnancies to understand how different monitoring methods might help improve the care for mothers and their babies. The researchers want to see if following specific guidelines and checking on these pregnancies more regularly can lead to better outcomes, meaning fewer complications for both mothers and their twins. This information will help doctors provide more accurate advice to families expecting twins.
To participate in the trial, women must be over 18 years old and currently pregnant with twins. They also need to have their ultrasounds and deliveries at a specific hospital in Bologna, Italy, and must agree to take part by signing a consent form. If you join the study, you can expect to have regular check-ups and monitoring during your pregnancy, which may help identify any potential issues early. This trial is important because it aims to improve the overall experience and health outcomes for twin pregnancies.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age \> 18 years
- • Twin Pregnancy
- • Ultrasound monitoring and delivery occurred at Policlinico S Orsola in Bologna, Italy
- • Written informed consent form obtained from the patient
- Exclusion Criteria:
- • Completion of delivery at another facility
- • Desire to undertake the Voluntary Interruption of Pregnancy
- • Refusal to undergo instrumental monitoring and subsequent follow-up at our center
About Irccs Azienda Ospedaliero Universitaria Di Bologna
IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, , Italy
Patients applied
Trial Officials
Gianluigi Pilu, MD
Principal Investigator
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported